Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Las Vegas Eye Surgeon Places First-Of-Its-Kind Lens Implant To Reduce Glasses And Glare For Cataract Patients
  • USA - English


News provided by

Stubenbordt Medical Marketing

Sep 01, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Kent Wellish, M.D.
Kent Wellish, M.D.

I’m really excited about the Tecnis Symfony Lens. It’s the first multifocal lens specifically designed to improve the full range of vision that can allow patients to reach their ultimate goal in reducing or eliminating their need for reading glasses.

Post this

Las Vegas, Nevada (PRWEB) September 01, 2016 -- Dr. Kent Wellish, Medical Director of the nationally recognized Wellish Vision Institute in Las Vegas, continues to make headway with improving patients vision after undergoing cataract surgery. Dr. Wellish has successfully implanted the first Tecnis Symfony Lens in several patients. This state-of-the-art intraocular lens was recently approved by the FDA, and has been used successfully in Europe and Canada for several years. The Tecnis Symfony Lens is manufactured by Abbott Medical Optics and is the first multifocal IOL that is specifically designed to allow for an extended range of vision at near, intermediate and distance. This produces less post-operative glare and halos at night when compared to other premium intraocular lenses. This leap forward in lens implant technology may allow patients undergoing cataract surgery to reduce or eliminate their need for reading glasses or bifocals following the procedure.

The Tecnis Symfony Lens is placed within the eye during cataract surgery, which is one of the most commonly performed procedures today. Over the years, the technology and techniques for performing cataract surgery have improved by leaps and bounds. Today, cataract surgery can be performed at an outpatient surgery center and often takes less than 10 minutes to complete. Most patients don’t require any sutures following the procedure and have a fast recovery time.

The first multifocal lens implant was approved in the late 90’s, enabling some patients to have a full range of vision. However, many patients had issues with glare and halos at night and didn’t have consistent clear vision at multiple ranges. Over the years, multifocal lens technology has dramatically improved. During clinical trials, the Tecnis Symfony Lens had a very low occurrence of nighttime glare and halos and allowed an extended range of vision for near, intermediate and distance vision. During the FDA studies, 97% of patients said they would choose to have the lens implanted again.

“I’m really excited about the Tecnis Symfony Lens. It’s the first multifocal lens specifically designed to improve the full range of vision that can allow patients to reach their ultimate goal in reducing or eliminating their need for reading glasses or bifocals. In addition, it has a low occurrence of nighttime glare and halos, which is typically associated with premium lenses. With the Tecnis Symfony Lens, the majority of patients will be able to do most things, most of the time with glasses. It’s very exciting!” says Dr. Wellish.

About Wellish Vision Institute

Since 1994, Wellish Vision Institute has been at the forefront of advanced vision correction, offering Las Vegas LASIK that is second to none at one of the most complete eye care centers in Nevada. Our commitment to patient care has led us to create a practice where our patients receive individualized treatment for LASIK refractive surgery, cataract surgery, and more with the latest technologies.

Wellish Vision Institute is a permanent on-site All-Laser iLASIK center in Las Vegas owned and operated by a Las Vegas “Top Doc,” an honor bestowed upon Dr. Wellish by peer physicians on multiple occasions. Dr. Wellish, Nevada’s First Laser Vision Surgeon Since 1994, has also been nationally recognized by Premier Surgeon Magazine for his work in cataract surgery. Additionally, Wellish Vision Institute has been nationally recognized as a Dry Eye Center of Excellence, offering Las Vegas residents state-of-the-art treatments for moderate to severe dry eye. Wellish Vision is currently part of three FDA Studies regarding some of the latest treatments for Cataract Surgery, Glaucoma and Dry Eye.

Contact Information
Wellish Vision Institute
Phone: 702-733-2020
http://www.WellishVisionInstitute.com

East Location
2110 East Flamingo Road
Suite 210 & 211
Las Vegas, NV 89119

West Location
2555 Box Canyon Dr.
Las Vegas, NV 89128

Paul Stubenbordt, Stubenbordt Medical Marketing, http://stubenbordt.com/, +1 682-831-0900 Ext: 105, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.